CROSSROADS STRATEGIES, LLC for GENENTECH, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.34, 21st Century Cures Act (P.L.114-255). S.2912, Trickett Wendler Right to Try Act of 2016. Issues related to Pharma supply chain and 340B Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Medicare/Medicaid MMM
Medicare reimbursement issues. H.R.5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models; issues related to Demonstration Programs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Budget/Appropriations BUD
S.3040/H.R.5926, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.5054/S.2956, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; H.R.2028, Further Continuing and Security Assistance Appropriations Act, 2017 (P.L.114-254); vial size issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.